Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Polymers for extended-release administration

Polymers for extended-release administration

Thumbnail Image
Download
Name

10544_2019_386_ReferencePDF.pdf

Size

1.56 MB

Format

Adobe PDF

Checksum (MD5)

dbb31813547e6062ddbfbe92f0f0d3c0

Download all files submitted through automated deposit
art_1138002470991687098.zip (1.36 MB)
Author(s)
Paolini, Marion
•
Fenton, Owen Shea
•
Bhattacharya, Chandrabali
•
Andresen, Jason
•
Langer, Robert S
Date Issued
April 2019
Journal
Biomedical Microdevices
Publisher
Springer Science and Business Media LLC
Citation
Paolini, Marion S. et al. "Polymers for extended-release administration." Biomedical Microdevices 21, 2 (April 2019): 45 © 2019 Springer Science Business Media, LLC
Version
Author's final manuscript
Abstract
Developing strategies to deliver the required dose of therapeutics into target tissues and cell populations within the body is a principal aim of controlled release and drug delivery. Specifically, there is an interest in developing formulations that can achieve drug concentrations within the therapeutic window, for extended periods of time, with tunable release profiles, and with minimal complication and distress for the patient. To date, drug delivery systems have been developed to serve as depots, triggers, and carriers for therapeutics including small molecules, biologics, and cell-based therapies. Notably, the efficacy of these systems is intricately tied to the manner in which they are administered. For example, systemic and oral routes of administration are common, but both can result in rapid clearance from the organism. Towards this end, what formulation and administration route strategies are available to prolong the bioavailability of therapeutics? Here, we discuss historical and modern drug delivery systems, with the intention of exploring how properties including formulation, administration route and chemical structure influence the ability to achieve extended-release drug release profiles within the body.
MIT Department
Massachusetts Institute of Technology. Department of Chemistry
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/128523
DOI of Published Version
https://doi.org/10.1007/s10544-019-0386-9
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.